Member Exclusive

Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment

Future Medicinal Chemistry Editorial by Daniel Merk (Goethe University Frankfurt, Germany) discussing the potential of retinoid X receptor gamma-targeting agents to repair or reverse multiple sclerosis damage to the CNS through boosting remyelination.

Go to the profile of RegMedNet
Aug 12, 2016
0
0

Please sign in or register for FREE

No comments yet.